Orbimed-Advisors

AI_NATIVE detailed information: This accession holds the following tickers:[
  "AKRO",
  "AXSM",
  "EWTX",
  "TRVI",
  "INSM",
  "FBRX",
  "KRYS",
  "ORIC",
  "TIL",
  "ARGX",
  "CBLL",
  "EXAS",
  "APLS",
  "ALNY",
  "ABCL",
  "FOLD",
  "ITGR",
  "BSX",
  "SWTX",
  null,
  "BCAX",
  "SLRN",
  "AVBP",
  "TNGX",
  "GPCR",
  "IMTX",
  "THRD",
  "TERN",
  "TYRA",
  "ACET",
  "ADCT",
  "KROS",
  "GILD",
  "ANRO",
  "AVTX",
  "AMLX",
  "JANX",
  "BIOA",
  "PHGE",
  "DHAI",
  "SRRK",
  "FATE",
  "ISRG",
  "TARS",
  "IVVD",
  "NBIX",
  "KRRO",
  "NXTC",
  "NKTX",
  "PMVP",
  "PRLD",
  "QTTB",
  "RPTX",
  "SIBN",
  "TSBX",
  "WHWK",
  "IONS",
  null,
  null,
  "UNH",
  "PFE",
  "SPRY",
  "AMGN",
  "SYK",
  "TMO",
  null,
  "UPB",
  "RAPT",
  "TRAW",
  "RNA",
  "AGIO",
  "MBX",
  "NPCE",
  "RYTM",
  "DYN",
  "SCPH",
  "PASG",
  null,
  "VRTX",
  "EW",
  "THC",
  "NTRA",
  null,
  null,
  "CRVS",
  "ELVN",
  "IKNA",
  null,
  "KZR",
  "VSTM",
  "VIR",
  "XERS",
  "XFOR",
  "XENE",
  "XTNT",
  "VERA",
  null,
  "CCCC",
  "CRDF",
  "CGON",
  "CMPX",
  "CRBP",
  "CRNX",
  "CGEM",
  "CYTK",
  "IRON",
  "LLY"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 107
Total Value: 4035711615
Accession Number: 0001172661-25-002355
Form Type: 13F-HR
CIK: orbimed-advisors
Manager Name: Orbimed-Advisors

Data Enrichment

92% identified

98 identified9 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

107 positions • $4.0B total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 4 of 6

Sort by:

Adicet Bio, Inc.

ACET|007002108

Shares:11.4M

Value:$8.6M

% of Portfolio:0.2% ($8.6M/$4.0B)

ADC Therapeutics SA

ADCT|H0036K147

Shares:6.0M

Value:$8.4M

% of Portfolio:0.2% ($8.4M/$4.0B)

Prelude Therapeutics Inc

PRLD|74065P101

Shares:10.9M

Value:$8.4M

% of Portfolio:0.2% ($8.4M/$4.0B)

78464A870

Shares:100.0K

Value:$8.1M

% of Portfolio:0.2% ($8.1M/$4.0B)

Avalo Therapeutics, Inc.

AVTX|05338F306

Shares:967.0K

Value:$7.7M

% of Portfolio:0.2% ($7.7M/$4.0B)

SpringWorks Therapeutics, Inc.

SWTX|85205L107

Shares:172.6K

Value:$7.6M

% of Portfolio:0.2% ($7.6M/$4.0B)

Whitehawk Therapeutics, Inc.

WHWK|00032Q104

Shares:4.2M

Value:$7.4M

% of Portfolio:0.2% ($7.4M/$4.0B)

Akero Therapeutics, Inc.

AKRO|00973Y108

Shares:179.9K

Value:$7.3M

% of Portfolio:0.2% ($7.3M/$4.0B)

PMV Pharmaceuticals, Inc.

PMVP|69353Y103

Shares:6.5M

Value:$7.1M

% of Portfolio:0.2% ($7.1M/$4.0B)

Trevi Therapeutics, Inc.

TRVI|89532M101

Shares:1.1M

Value:$7.0M

% of Portfolio:0.2% ($7.0M/$4.0B)

G52441105

Shares:250.0K

Value:$6.2M

% of Portfolio:0.2% ($6.2M/$4.0B)

Corbus Pharmaceuticals Holdings, Inc.

CRBP|21833P301

Shares:1.2M

Value:$6.2M

% of Portfolio:0.2% ($6.2M/$4.0B)

45779A846

Shares:2.1M

Value:$5.7M

% of Portfolio:0.1% ($5.7M/$4.0B)

Scholar Rock Holding Corp

SRRK|80706P103

Shares:151.8K

Value:$4.9M

% of Portfolio:0.1% ($4.9M/$4.0B)

Forte Biosciences, Inc.

FBRX|34962G208

Shares:593.1K

Value:$4.6M

% of Portfolio:0.1% ($4.6M/$4.0B)

Ikena Oncology, Inc.

IKNA|45175G108

Shares:3.5M

Value:$4.5M

% of Portfolio:0.1% ($4.5M/$4.0B)

000000000

Shares:5.7M

Value:$4.4M

% of Portfolio:0.1% ($4.4M/$4.0B)

Krystal Biotech, Inc.

KRYS|501147102

Shares:23.5K

Value:$4.2M

% of Portfolio:0.1% ($4.2M/$4.0B)

29286M105

Shares:891.6K

Value:$4.0M

% of Portfolio:0.1% ($4.0M/$4.0B)

Oric Pharmaceuticals, Inc.

ORIC|68622P109

Shares:700.0K

Value:$3.9M

% of Portfolio:0.1% ($3.9M/$4.0B)

Instrument	Shares		Other Manager	Value	% of Portfolio
Adicet Bio, Inc.(ACETcusip007002108)	11.4M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$8.6M	0.2% ($8.6M/$4.0B)	QoQ -21.51% (-$2.4M) YoY -67.87% (-$18.3M)
ADC Therapeutics SA(ADCTcusipH0036K147)	6.0M	QoQ 0.00% (-0) YoY NEW(+6.0M)	All Managers (Combined)	$8.4M	0.2% ($8.4M/$4.0B)	QoQ -29.14% (-$3.5M) YoY NEW(+$8.4M)
Prelude Therapeutics Inc(PRLDcusip74065P101)	10.9M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$8.4M	0.2% ($8.4M/$4.0B)	QoQ -39.76% (-$5.5M) YoY -83.79% (-$43.3M)
(cusip78464A870)✕	100.0K	QoQ -73.11% (-272.0K) YoY NEW(+100.0K)	All Managers (Combined)	$8.1M	0.2% ($8.1M/$4.0B)	QoQ -75.79% (-$25.4M) YoY NEW(+$8.1M)
Avalo Therapeutics, Inc.(AVTXcusip05338F306)	967.0K	QoQ 0.00% (+0) YoY NEW(+967.0K)	All Managers (Combined)	$7.7M	0.2% ($7.7M/$4.0B)	QoQ +7.80% (+$560.9K) YoY NEW(+$7.7M)
SpringWorks Therapeutics, Inc.(SWTXcusip85205L107)	172.6K	QoQ -86.24% (-1.1M) YoY -89.89% (-1.5M)	All Managers (Combined)	$7.6M	0.2% ($7.6M/$4.0B)	QoQ -83.20% (-$37.7M) YoY -90.93% (-$76.4M)
Whitehawk Therapeutics, Inc.(WHWKcusip00032Q104)	4.2M	QoQ NEW(+4.2M) YoY NEW(+4.2M)	All Managers (Combined)	$7.4M	0.2% ($7.4M/$4.0B)	QoQ NEW(+$7.4M) YoY NEW(+$7.4M)
Akero Therapeutics, Inc.(AKROcusip00973Y108)	179.9K	QoQ +172.57% (+113.9K) YoY NEW(+179.9K)	All Managers (Combined)	$7.3M	0.2% ($7.3M/$4.0B)	QoQ +296.61% (+$5.4M) YoY NEW(+$7.3M)
PMV Pharmaceuticals, Inc.(PMVPcusip69353Y103)	6.5M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$7.1M	0.2% ($7.1M/$4.0B)	QoQ -27.81% (-$2.7M) YoY -35.88% (-$3.9M)
Trevi Therapeutics, Inc.(TRVIcusip89532M101)	1.1M	QoQ NEW(+1.1M) YoY NEW(+1.1M)	All Managers (Combined)	$7.0M	0.2% ($7.0M/$4.0B)	QoQ NEW(+$7.0M) YoY NEW(+$7.0M)
(cusipG52441105)✕	250.0K	QoQ NEW(+250.0K) YoY NEW(+250.0K)	All Managers (Combined)	$6.2M	0.2% ($6.2M/$4.0B)	QoQ NEW(+$6.2M) YoY NEW(+$6.2M)
Corbus Pharmaceuticals Holdings, Inc.(CRBPcusip21833P301)	1.2M	QoQ 0.00% (-0) YoY NEW(+1.2M)	All Managers (Combined)	$6.2M	0.2% ($6.2M/$4.0B)	QoQ -55.00% (-$7.6M) YoY NEW(+$6.2M)
(cusip45779A846)✕	2.1M	QoQ 0.00% (+0) YoY 0.00% (+0)	All Managers (Combined)	$5.7M	0.1% ($5.7M/$4.0B)	QoQ +2.28% (+$128.0K) YoY +13.49% (+$682.5K)
Scholar Rock Holding Corp(SRRKcusip80706P103)	151.8K	QoQ 0.00% (-0) YoY -95.75% (-3.4M)	All Managers (Combined)	$4.9M	0.1% ($4.9M/$4.0B)	QoQ -25.61% (-$1.7M) YoY -92.31% (-$58.6M)
Forte Biosciences, Inc.(FBRXcusip34962G208)	593.1K	QoQ -1.15% (-6.9K) YoY NEW(+593.1K)	All Managers (Combined)	$4.6M	0.1% ($4.6M/$4.0B)	QoQ -66.22% (-$9.0M) YoY NEW(+$4.6M)
Ikena Oncology, Inc.(IKNAcusip45175G108)	3.5M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$4.5M	0.1% ($4.5M/$4.0B)	QoQ -21.95% (-$1.3M) YoY -9.85% (-$495.5K)
(cusip000000000)✕	5.7M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$4.4M	0.1% ($4.4M/$4.0B)	QoQ -39.76% (-$2.9M) YoY -83.79% (-$22.6M)
Krystal Biotech, Inc.(KRYScusip501147102)	23.5K	QoQ 0.00% (+0) YoY -36.77% (-13.7K)	All Managers (Combined)	$4.2M	0.1% ($4.2M/$4.0B)	QoQ +15.09% (+$555.5K) YoY -35.92% (-$2.4M)
(cusip29286M105)✕	891.6K	QoQ -3.12% (-28.7K) YoY NEW(+891.6K)	All Managers (Combined)	$4.0M	0.1% ($4.0M/$4.0B)	QoQ -34.73% (-$2.1M) YoY NEW(+$4.0M)
Oric Pharmaceuticals, Inc.(ORICcusip68622P109)	700.0K	QoQ NEW(+700.0K) YoY +143.81% (-412.9K)	All Managers (Combined)	$3.9M	0.1% ($3.9M/$4.0B)	QoQ NEW(+$3.9M) YoY -1.05% (-$41.6K)